Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.3K
Overview
64.3K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

823
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
823
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Complement System01:27

Complement System

10.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients.

Virology journal·2026
Same author

Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor access.

Kidney international·2026
Same author

Prescription of off-label medications in patients on dialysis: time to challenge contraindications?

Clinical kidney journal·2026
Same author

The inhibitory receptor NKG2A is expressed on T-cells during BKPyVANephropathy.

Frontiers in immunology·2026
Same author

CONFIDENT-HFpEF: A Machine Learning-Based Risk Stratification for Mortality and Hospitalization Using Multimodal Real-World Data.

ESC heart failure·2026
Same author

Copeptin is a reliable biomarker of vasopressin and is associated with urine osmolality in patients on peritoneal dialysis.

Journal of nephrology·2026
Same journal

Meta-analysis of the impact of donor hepatitis C infection on kidney transplantation outcomes.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Center-based obstacles and facilitators in the utilization of kidney paired donation in the United States, 2008-2023: A scoping review.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Defining delayed graft function in kidney transplantation: A scoping review of outcome reporting practices.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Utility of genetic testing in heart transplant recipients: a systematic review and meta-analysis.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

Incretin therapy and transplant readiness: Distinguishing BMI-based access from physiologic reserve in solid organ transplantation.

Transplantation reviews (Orlando, Fla.)·2026
Same journal

The applications of single cell RNA-seq and spatial transcriptomics in organ transplantation.

Transplantation reviews (Orlando, Fla.)·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

8.8K

Complement modulation in solid-organ transplantation.

Maxime Touzot1, Erika Nnang Obada2, Severine Beaudreuil1

  • 1Nephrology Department, IFRNT, Le Kremlin-Bicêtre, France; Institut National de la Santé et de la Recherche Médicale INSERM U1014, Villejuif, France.

Transplantation Reviews (Orlando, Fla.)
|July 6, 2014
PubMed
Summary
This summary is machine-generated.

The complement system, crucial for immunity, can cause graft injury in organ transplants when dysregulated. Blocking terminal complement activation with drugs like eculizumab shows promise for managing rejection.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

13.8K
A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
08:33

A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation

Published on: March 20, 2026

73

Related Experiment Videos

Last Updated: Apr 27, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

8.8K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

13.8K
A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
08:33

A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation

Published on: March 20, 2026

73

Area of Science:

  • Immunology
  • Transplantation Biology
  • Innate Immunity

Background:

  • The complement system is a key part of innate immunity, essential for pathogen defense.
  • Dysregulation of complement activation contributes to tissue injury and influences adaptive immunity.
  • In organ transplantation, complement activation is implicated in hyperacute and antibody-mediated rejection.

Purpose of the Study:

  • To review the role of local complement activation in acute and chronic graft injury.
  • To discuss recent clinical trial advances in blocking complement activation, particularly with anti-C5 monoclonal antibody eculizumab.
  • To explore the integration of complement-targeted therapy into current immunosuppressive regimens and identify patient populations who would benefit most.

Main Methods:

  • Review of current literature on complement system activation in organ transplantation.
  • Analysis of clinical trial data for therapies targeting terminal complement activation.
  • Discussion of the pathophysiology of antibody-mediated rejection and complement's role.

Main Results:

  • Local complement activation significantly contributes to acute and chronic graft injury in organ transplantation.
  • Clinical trials using eculizumab demonstrate potential in blocking terminal complement activation and mitigating rejection.
  • Emerging insights into antibody-mediated rejection pathophysiology highlight complement's central role.

Conclusions:

  • Complement activation is a critical factor in organ transplant rejection, driving both acute and chronic injury.
  • Targeting terminal complement activation, exemplified by eculizumab, offers a promising therapeutic strategy.
  • Personalized complement-targeted therapies may enhance immunosuppressive regimens, improving outcomes for specific transplant recipients.